MSN: COVID-19 vaccine study

UC faculty members involved in upcoming trial at Cincinnati Children's studying a new vaccine

Cincinnati Children's Hospital Medical Center will begin human trials for a COVID-19 vaccine in the upcoming weeks, and the screening process has already begun for people who want to participate.

"We are excited about this vaccine and think it has the possibility to decrease the risk of infection from COVID-19,” says Robert Frenck, MD, who will lead the study. Frenck is a professor of pediatrics at the UC College of Medicine and is medical director for the Division of Infectious Diseases and director of the Vaccine Research Center at Cincinnati Children's.

Watch the full WCPO-TV, Channel 9 story.

Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine and a UC Health physician, applauded the efforts and expertise of his colleagues.

"It's a very cool study design that allows for flexibility," he says. "Cincinnati Children's is a powerhouse in vaccine development, going back to the days of Albert Sabin and the development of the polio vaccine."

Read the full article.

Fichtenbaum also weighed in on other promising vaccine studies, like those coming from  Massachusetts-based Moderna, Incorporated and another by researchers at Oxford University.

Watch the full WLWT-TV, Channel 5 story.

Featured photo/Colleen Kelley/UC Creative + Brand

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.